Explore more
News
A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their ...
A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...
I worry about how these changes, which are occurring at the age of 13 or 14, might affect them later in life,” the study’s ...
A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive ...
Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...
Alabama has moved up the most recent obesity rankings from U.S. News & World Report. And we’re getting awfully close to the ...
When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
Many are from the most deprived areas, and a significant number are neurodivergent or have other health conditions, a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback